标题
The state of the art on treatment of Crohn’s disease
作者
关键词
Crohn’s disease, Biologics, Mucosal healing, Target
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-06
DOI
10.1007/s00535-018-1479-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
- (2018) Gary R Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease
- (2017) Parakkal Deepak et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- The PROSIT-BIO Cohort
- (2017) Gionata Fiorino et al. INFLAMMATORY BOWEL DISEASES
- Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohnʼs Disease
- (2017) Stephanie Coward et al. INFLAMMATORY BOWEL DISEASES
- European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
- (2017) Glen Doherty et al. Journal of Crohns & Colitis
- Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort
- (2017) B Lo et al. Journal of Crohns & Colitis
- Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease
- (2017) Yun Qiu et al. JOURNAL OF GASTROENTEROLOGY
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
- (2017) Benjamin L Cohen et al. BMJ-British Medical Journal
- Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
- (2017) Benjamin L Cohen et al. BMJ-British Medical Journal
- Thalidomide induces clinical remission and mucosal healing in adults with active Crohn’s disease: a prospective open-label study
- (2017) Yao He et al. Therapeutic Advances in Gastroenterology
- Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
- (2016) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
- (2016) E. J. Mao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
- (2016) D. C. Baumgart et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn’s Disease
- (2016) Marion Simon et al. Clinical Gastroenterology and Hepatology
- Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation
- (2016) Shomron Ben-Horin et al. Clinical Gastroenterology and Hepatology
- Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
- (2016) Aurelien Amiot et al. Clinical Gastroenterology and Hepatology
- Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
- (2016) Stefanos Bonovas et al. Clinical Gastroenterology and Hepatology
- A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s disease
- (2016) Konstantinos Papamichael et al. Expert Opinion On Drug Safety
- The Changing Landscape of Inflammatory Bowel Disease: East Meets West
- (2016) Gilaad G. Kaplan et al. GASTROENTEROLOGY
- Epidemiology of Inflammatory Bowel Disease from 1981 to 2014
- (2016) Siew C. Ng et al. INFLAMMATORY BOWEL DISEASES
- Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases
- (2016) Hans H. Herfarth et al. INFLAMMATORY BOWEL DISEASES
- How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems
- (2016) Anna M. Buchner et al. INFLAMMATORY BOWEL DISEASES
- Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease
- (2016) Andrew R. Reinink et al. INFLAMMATORY BOWEL DISEASES
- Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease
- (2016) Clare Moore et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
- (2016) Paolo Gionchetti et al. Journal of Crohns & Colitis
- Thalidomide for inflammatory bowel disease
- (2016) Matteo Bramuzzo et al. MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2015) A. Bourrier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials
- (2015) Jennifer L. Jones et al. Clinical Gastroenterology and Hepatology
- Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
- (2015) Guillaume Bouguen et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients
- (2015) Edward Shelton et al. INFLAMMATORY BOWEL DISEASES
- Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- Asia-Pacific consensus statements on Crohn's disease. Part 2: Management
- (2015) Choon Jin Ooi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Biologic agents for IBD: practical insights
- (2015) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Clinical predictors of thiopurine-related adverse events in Crohn's disease
- (2015) Gordon W Moran WORLD JOURNAL OF GASTROENTEROLOGY
- Toxicity and response to thiopurines in patients with inflammatory bowel disease
- (2015) Rimma Goldberg et al. Expert Review of Gastroenterology & Hepatology
- Optimizing the use of thiopurines in inflammatory bowel disease
- (2015) Rishi M. Goel et al. Therapeutic Advances in Chronic Disease
- Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of IBD: Where We Are and Where We Are Going
- (2014) Charles N Bernstein AMERICAN JOURNAL OF GASTROENTEROLOGY
- Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease
- (2014) Nicolas Williet et al. Clinical Gastroenterology and Hepatology
- Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease
- (2014) Anthony Lopez et al. Clinical Gastroenterology and Hepatology
- Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease
- (2014) Heimo H. Wenzl et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
- (2014) Bruce E. Sands et al. GASTROENTEROLOGY
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
- (2014) Suk-Kyun Yang et al. NATURE GENETICS
- A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
- (2013) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab
- (2013) Fernando S. Velayos et al. Clinical Gastroenterology and Hepatology
- Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC
- (2013) Marc Ferrante et al. GASTROENTEROLOGY
- Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
- (2013) Mark T. Osterman et al. GASTROENTEROLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011
- (2013) Christine Rungoe et al. GUT
- Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
- (2013) Laurent Peyrin-Biroulet et al. GUT
- Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease
- (2013) Marzia Lazzerini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
- (2013) J. Panes et al. Journal of Crohns & Colitis
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
- (2013) Ole Haagen Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
- (2012) T.-F. Tsai et al. BRITISH JOURNAL OF DERMATOLOGY
- Hospitalisations and surgery in Crohn's disease
- (2012) Charles N Bernstein et al. GUT
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Oral locally active steroids in inflammatory bowel disease
- (2012) Tiago Nunes et al. Journal of Crohns & Colitis
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
- (2011) Mamoru Watanabe et al. Journal of Crohns & Colitis
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
- (2010) B. Jharap et al. INFLAMMATORY BOWEL DISEASES
- Magnetic resonance imaging for evaluation of Crohnʼs disease
- (2010) Jordi Rimola et al. INFLAMMATORY BOWEL DISEASES
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome
- (2010) L. G. Schipper et al. RHEUMATOLOGY
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts
- (2009) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
- (2009) J. Rimola et al. GUT
- Prevalence of ulcerative colitis and Crohn’s disease in Japan
- (2009) Keiko Asakura et al. JOURNAL OF GASTROENTEROLOGY
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease
- (2008) Kelvin T. Thia et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study
- (2007) Suk-Kyun Yang et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now